28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 9000 - 9200 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|---|
| nhsd.assets.stu3 | R3 | eRS-RequestFlowType-1 | eRS Request Flow Type | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-FetchOutcomeType-1 | DO NOT USE - eRS Fetch Outcome Type | retired | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-Specialty-1 | eRS Referral Type | active | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-Specialty-1 | eRS Specialty | draft | hl7 | |||||
| uk.nhsdigital.r4.test | R4 | c4880a00-b908-4877-9b71-4f3b8a50faee | NHSDigitaleRSSpecialty | draft | ||||||
| nhsd.assets.stu3 | R3 | eRS-ReferralRequestStatus-1 | eRS Referral Request Status | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | ValueSet-eRS-AppointmentType-1 | eRS Appointment Type | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-CapacityAlert-1 | eRS Capacity Alert | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-CapacityStatus-1 | eRS Capacity Status | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-RequestType-1 | eRS Request Type | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-ServiceSearch-SortBy-1 | eRS ServiceSearch Sort By - DO NOT USE | retired | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-SortBy-1 | eRS Sort By | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-IWT-1 | eRS Indicative Wait Time | draft | hl7 | |||||
| nhsd.assets.stu3 | R3 | eRS-ReferralLetterIntention-1 | eRS Referral Letter Intention | draft | hl7 | |||||
| hl7.terminology | R5 | v3-ParticipationAuthenticator | ParticipationAuthenticator | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ParticipationLegalAuthenticator | ParticipationLegalAuthenticator | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-SwabDrugForm | SwabDrugForm | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-PersonalAndLegalRelationshipRoleType | PersonalAndLegalRelationshipRoleType | active | 2023-06 | uv | hl7 | tho | ||
| de.basisprofil.r4 | R4 | valueset-wg14 | WG14 ValueSet | active | 2025-06 | hl7 | ||||
| HIE2.packages | R4 | results-laboratory-blood-abo-rh-grp-gps-uv-ips | Results Laboratory ABO+RH Group (GPS) - IPS | active | 2022-01 | uv | hl7 | sct | ||
| hl7.fhir.us.registry-protocols | R4 | LesionComplexity | Complexity of the Lesion | active | cic | 2023-11 | us | hl7 | fhir | |
| hl7.fhir.us.registry-protocols | R4 | CABGIndication | CABG Indication | active | cic | 2023-11 | us | hl7 | fhir | |
| de.gecco | R4 | 1.2.276.0.76.11.499--20200504224822 | ACE inhibitors ATC | active | ||||||
| hl7.fhir.us.medmorph | R4 | us-ph-computable-valueset-example | US Public Health Computable ValueSet Example | draft | 2022-07 | us | hl7 | |||
| hl7.fhir.us.ecr | R4 | us-ph-computable-valueset-example | US Public Health Computable ValueSet Example | draft | 2022-05 | us | hl7 | |||
| hl7.fhir.us.ph-library | R4 | us-ph-valueset-computable-example | US Public Health ValueSet - Computable Example | draft | 2022-07 | us | hl7 | |||
| hl7.fhir.us.breast-radiology | R4 | rde1562-laterality-from-landmark | RDE1562 Laterality from landmark | draft | 2022-10 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1565-type | RDE1565 Type | draft | 2022-10 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1568-distribution | RDE1568 Distribution | draft | 2022-12 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1571-associated-features | RDE1571 Associated features | draft | 2022-11 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1576-shape | RDE1576 Shape | draft | 2022-11 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1577-type | RDE1577 Type | draft | 2022-10 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1578-density | RDE1578 Density | draft | 2022-10 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1579-margin | RDE1579 Margin | draft | 2022-10 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1580-orientation | RDE1580 Orientation | draft | 2022-10 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1586-assessment-category | RDE1586 Assessment category | draft | 2022-11 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1587-breast-composition-category | RDE1587 Breast composition category | draft | 2022-11 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1588-breast-laterality | RDE1588 Breast laterality | draft | 2022-11 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1589-implant-presence | RDE1589 Implant presence | draft | 2022-11 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1590-prior-mastectomy | RDE1590 Prior mastectomy | draft | 2022-11 | us | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | rde1602-type | RDE1602 Type | draft | 2022-12 | us | hl7 | fhir | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1096 | Rash Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1089 | Botulism-like Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1099 | Specific Infection Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1091 | Gastrointestinal Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1097 | Respiratory Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1095 | Neurological Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1098 | Severe Illness Or Death Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1090 | Fever Syndrome (BT) | active | 2008-01 | us | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1094 | Lymphadenitis Syndrome (BT) | active | 2008-01 | us | fhir | |||
| hl7.fhir.it.lab-report | R4 | aifa-aic | AIFA AIC | active | 2024-03 | it | hl7 | internal | ||
| hl7.fhir.it.terminology | R4 | aifa-ge | AIFA Gruppo di Equivalenza | active | 2025-06 | it | hl7 | internal | ||
| dk.kip.rkkp.fhir.ig.core | R4 | AKBehandlingDKR | AK Behandling (DKR) | active | 2022-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ALDkemoterapi | ALD_Kemoterapi | active | 2024-07 | internal | ||||
| vzvz.fhir.aof | R4B | DataCategory | AORTA DataCategory ValueSet | draft | 2024-11 | nl | oid | |||
| vzvz.fhir.aof | R4B | aorta-datareference-update-reason | AORTA DataReference Update Reason ValueSet | draft | 2023-12 | nl | ||||
| vzvz.fhir.aof | R4B | aorta-Code | AORTA-Code ValueSet | draft | 2024-11 | nl | oid | |||
| vzvz.fhir.aof | R4B | aorta-taskcode | AORTA-taskcode ValueSet | draft | 2022-09 | nl | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | APInstabilitetDKR | AP-instabilitet (DKR) | active | 2022-10 | internal | ||||
| medcom.fhir.dk.xdsdocuments | R4 | medcom-dk-xds-apd-formatcode-VS | APD-DK IHE FormatCode | active | 2020-05 | dk | oid | |||
| intraproc.anesthesia | R4 | asagrade-vs | ASA Grade | draft | 2025-05 | sct | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ASAIVI | ASA klassifikation I-VI | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ASAIVIkort | ASA klassifikation I-VI Kort | active | 2022-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | AsaIV | ASA klassifikation I-V | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | AsaIVkort | ASA klassifikation I-V Kort | active | 2022-10 | internal | ||||
| medmij.dental.care.r4 | R4 | DentalCare-ASAScore | DentalCare - ASA Score | draft | sct | |||||
| hsg.asg-well | R4B | asg-cs-outcome | asg-cs-outcome | active | 2025-04 | |||||
| hsg.asg-well | R4B | asg-observation-type | asg-observation-type | active | 2025-04 | |||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCAntibiotikaprofylakseDKR | ATC - Antibiotikaprofylakse (DKR) | active | 2022-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCAntibiotikaprofylakseDosisDKR | ATC - Antibiotikaprofylakse, dosis (DKR) | active | 2022-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCAntibiotikaprofylakseVarighedDKR | ATC - Antibiotikaprofylakse, varighed (DKR) | active | 2022-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCTromboseprofylakseDKR | ATC - Tromboseprofylakse (DKR) | active | 2022-10 | internal | ||||
| hl7.org.nz.fhir.ig.formulary | R4B | atc-code | ATC codes | active | 2025-07 | nz | hl7 | atc | ||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCDMPN | ATC DMPN | active | 2022-07 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCDMPN202410 | ATC DMPN 202410 | active | 2024-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCChemoPreparation | ATC: Præparater for kemobehandling | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCImmunotherapyCLL | ATC_CLL_immunterapi | active | 2022-07 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCChemoCLL | ATC_CLL_kemo | active | 2022-07 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ATCTargetCLL | ATC_CLL_target | active | 2022-07 | internal | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) | active | 2018-01 | us | sct tho | |||
| nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.355--20220117102535 | AanUitKleden_GZ | active | nl | sct | ||||
| nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.2.8--20200901000000 | AanUitkledenCodelijst | active | nl | oid | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.4--20200901000000 | AanduidingBijNummerCodelijst | active | nl | hl7 | oid | |||
| nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.265--20210525145536 | Aanvang Probleem | active | nl | sct | ||||
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.45--20220310164013 | Aanvullende Informatie voor MA | active | 2022-04 | nl | oid | |||
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.33--20170505131418 | Aanvullende informatie voor VS | active | nl | oid | ||||
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.32--20230109105413 | Aanvullende wensen voor VV | draft | 2023-01 | nl | oid | |||
| nictiz.fhir.nl.stu3.zib2015 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.9.10.1--20171231000000 | AanvullendeWensenCodelijst | retired | nl | oid | ||||
| de.aqua.ebi | R4 | EBI-VS-Versorgungsart | EBI_VS_Versorgungsart | draft | 2022-04 | tho | ||||
| hl7.terminology | R5 | verificationresult-can-push-updates | Can-push-updates | active | pa | 2024-04 | uv | hl7 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3343 | Abnormal Flag (HL7 27) | active | 2010-01 | us | oid | |||
| agha.fhir.genclipr | R4 | AbnormalClinicalFindings | Abnormal Clinical Findings Value Set | active | 2022-03 | sct | ||||
| ca.on.oh-olis | R4 | olis-InterpretationProvider | Interpretation | active | hl7 | tho | ||||
| hl7.fhir.us.breast-radiology | R4 | rde1556-presence | RDE1556 Presence | draft | 2022-12 | us | hl7 | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.34 | AbnormalityOfGaitAndMobility | active | 2021-07 | us | hl7 | icd | ||
| HIE2.packages | R4 | absent-or-unknown-allergies-uv-ips | Absent or Unknown Allergies - IPS | active | 2022-01 | uv | hl7 | fhir | ||
| hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.61--20180127221947 | Absent or Unknown Devices | draft | 2024-08 | uv | hl7 | fhir | ||
| HIE2.packages | R4 | absent-or-unknown-immunizations-uv-ips | Absent or Unknown Immunization - IPS | active | 2022-01 | uv | hl7 | fhir | ||
| HIE2.packages | R4 | absent-or-unknown-medications-uv-ips | Absent or Unknown Medication - IPS | active | 2022-01 | uv | hl7 | fhir | ||
| HIE2.packages | R4 | absent-or-unknown-problems-uv-ips | Absent or Unknown Problems - IPS | active | 2022-01 | uv | hl7 | fhir | ||
| hl7.eu.fhir.pcsp | R4 | absent-or-unknown-procedures-uv-ips | Absent or Unknown Procedures - IPS | trial-use | 2 | 2022-11 | eu | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3344 | Accept Application Acknowledgment Conditions (HL7) | active | 2017-01 | us | tho | |||
| hl7.fhir.us.mcode | R4 | mcode-tumor-size-units-vs | Tumor Size Units Value Set | active | 3 | cic | 2025-02 | us | hl7 | ucum |
| ca.on.oh.corhealth | R4 | CorHealth116AccessSiteVS | Access Site | active | ||||||
| hl7.terminology | R5 | cql-access-modifier | CQL Access Modifier | draft | cds | 2024-02 | uv | hl7 | tho | |
| hl7.terminology | R5 | v3-ActEncounterAccommodationCode | ActEncounterAccommodationCode | active | 2014-03 | uv | hl7 | tho | ||
| dk.kip.rkkp.fhir.ig.core | R4 | AcetabulumKnogletabKlassifikationDHR | Acetabulum knogletab klassifikation (DHR) | active | 2022-11 | internal | ||||
| hl7.terminology | R5 | v3-AcknowledgementCondition | AcknowledgementCondition | active | 2014-03 | uv | hl7 | tho | ||
| vital-records-fhir-messaging | R4 | VRM-AcknowledgementHeaderURI-vs | Acknowledgement MessageHeader URI Values | draft | 2025-07 | cdc | ||||
| hl7.terminology | R5 | v3-AcknowledgementType | AcknowledgementType | active | 2014-03 | uv | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.958 | Acknowledgment Code (HL7) | active | 2008-01 | us | tho | |||
| tw.gov.mohw.emr | R4 | AcquisitionModality | Acquisition Modality | active | 2023-09 | tw | national | internal | ||
| ee.hl7.fhir.base.r5 | R5 | ee-act-priority | Act Priority | draft | 2023-08 | ee | hl7 | tho | ||
| ee.fhir.terminology | R5 | act-priority | Act Priority | active | 2025-06 | ee | hl7 | tho | ||
| hl7.terminology | R5 | v3-ActConsentDirectiveType | ActConsentDirectiveType | active | sec | 2019-03 | uv | hl7 | tho | |
| hl7.terminology | R5 | v3-ActConsentDirective | ActConsentDirective | active | 2014-03 | uv | hl7 | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActEncounterCode-cisis | ActEncounterCode | active | 2025-06 | fr | national | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActMood-cisis | ActMood | active | 2025-06 | fr | national | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActMoodIntent-cisis | ActMoodIntent | active | 2025-06 | fr | national | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActPharmacySupplyType-cisis | ActPharmacySupplyType | active | 2025-06 | fr | national | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActPriority-cisis | ActPriority | active | 2025-06 | fr | national | tho | ||
| hl7.terminology | R5 | v3-ActPrivacyLaw | ActPrivacyLaw | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ActPrivacyPolicy | ActPrivacyPolicy | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ActInformationSensitivityPolicy | ActInformationSensitivityPolicy | active | 2014-03 | uv | hl7 | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActStatus-cisis | ActStatus | active | 2025-06 | fr | national | tho | ||
| hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.22--20170502000000 | ActStatusActiveCompletedAbortedCancelled | draft | 2024-08 | uv | hl7 | tho | ||
| hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.12--20170330000000 | ActStatusActiveCompletedAbortedSuspended | draft | 2024-08 | uv | hl7 | tho | ||
| ch.fhir.ig.ch-term | R4 | ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCode | active | 2025-05 | ch | hl7 | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActSubstanceAdminSubstitutionCode-cisis | ActSubstanceAdminSubstitutionCode | active | 2025-06 | fr | national | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActSubstanceAdministrationCode-cisis | ActSubstanceAdministrationCode | active | 2025-06 | fr | national | tho | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-ActSubstanceAdministrationImmunizationCode-cisis | ActSubstanceAdministrationImmunizationCode | active | 2025-06 | fr | national | tho | ||
| ans.fr.nos | R4 | JDV-J16-ActeSpecifique-ROR | JDV_J16-ActeSpecifique-ROR | active | 2025-01 | fr | national | |||
| signal.core.r4 | R4 | questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 1 | pa | us | hl7 | ||
| ans.fr.nos | R4 | JDV-J242-ActionAnomalie-ROR | JDV_J242-ActionAnomalie-ROR | active | 2023-03 | fr | national | |||
| hl7.terminology | R5 | adverse-event-clinical-research-seriousness-criteria | Adverse Event Clinical Research Seriousness Criteria | active | 1 | brr | 2023-07 | uv | hl7 | ncit |
| dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-action-guidance-for-types | Action guidance For Types | active | 2021-10 | dk | fhir | |||
| dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-action-guidance-types | Action guidance types | active | 2021-10 | dk | ||||
| de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-action-selection-behavior-required | Action Selection Behavior Required | draft | 2022-11 | uv | hl7 | fhir | ||
| hl7.terminology | R5 | v3-ActAdjudicationResultActionCode | ActAdjudicationResultActionCode | active | 2014-03 | uv | hl7 | tho | ||
| hl7.fhir.nl.zorgviewer | R3 | ACPTreatmentCodelist | ACP behandelingen waardelijst | active | 2025-07 | nl | hl7 | sct | ||
| MyHIE.v4-test | R4 | value-set-active-ingredient-my-core | ValueSetActiveIngredient (MY Core) | active | 2023-01 | |||||
| MyHIE.v4-test | R4 | value-set-allergy-environment-my-core | ValueSetAllergyEnvironment (MY Core) | active | 2023-01 | |||||
| IdHIE.0v | R4 | value-set-active-ingredient-id-core | ValueSetActiveIngredient (ID Core) | active | 2023-06 | |||||
| IdHIE.0v | R4 | value-set-allergy-environment-id-core | ValueSetAllergyEnvironment (ID Core) | active | 2023-06 | |||||
| hl7.fhir.uv.cpg | R4 | cpg-active-condition-vs | CPG Active Condition Value Set | active | cds | 2024-11 | uv | hl7 | tho | |
| fhir.cqf.common | R4 | active-condition | CQF Active Condition | active | 2019-07 | us | hl7 | tho | ||
| hl7.eu.fhir.pcsp | R4 | activeResolved-condition-vs | Active or resolved Condition | draft | 2025-07 | eu | hl7 | tho | ||
| ch.fhir.ig.ch-term | R4 | ActivePharmaceuticalIngredient | ActivePharmaceuticalIngredient | active | 2025-05 | ch | hl7 | sct | ||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.13.3--20200901000000 | ActiviteitCodelijst | active | nl | hl7 | oid | |||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.13.3--20171231000000 | ActiviteitCodelijst | active | nl | oid | ||||
| dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-activitydefinition-code | Activity Definition Code | active | 2019-02 | dk | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8014 | Activity Type Anthrax | active | 2020-01 | us | tho oid | |||
| hl7.fhir.us.vrdr | R4 | vrdr-activity-at-time-of-death-vs | Activity at Time of Death ValueSet | active | pher | 2024-10 | us | hl7 | fhir tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) | active | 2008-01 | us | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) | active | 2020-01 | us | sct tho oid | |||
| ans.fr.nos | R4 | JDV-J17-ActiviteOperationnelle-ROR | JDV_J17-ActiviteOperationnelle-ROR | active | 2024-12 | fr | national | |||
| ans.fr.nos | R4 | JDV-J94-GenreActivite-RASS | JDV_J94-GenreActivite-RASS | active | 2024-03 | fr | national | |||
| ans.fr.terminologies | R4 | JDV-J69-ActiviteOperationnelle-Santefr | JDV J69 ActiviteOperationnelle Santefr | retired | 2024-05 | fr | national | |||
| ans.fr.nos | R4 | JDV-J133-ActiviteSanitaireRegulee-RASS | JDV_J133-ActiviteSanitaireRegulee-RASS | active | 2020-11 | fr | national | |||
| ch.fhir.ig.ch-epr-fhir | R4 | PpqmActorIdentifierType | CH PPQm Actor Identifier Type | active | 2025-05 | ch | hl7 | ietf | ||
| ch.fhir.ig.ch-epr-ppqm | R4 | PpqmActorIdentifierType | PPQm Actor Identifier Type | active | 2023-12 | ch | hl7 | ietf | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) | active | 2020-01 | us | sct tho | |||
| hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-class | Acute Care Hospital Encounter Class ValueSet | trial-use | 1 | pher | 2025-07 | us | hl7 | tho |
| hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-status | Acute Care Hospital Encounter Status ValueSet | trial-use | 1 | pher | 2025-07 | us | hl7 | fhir |
| ca.on.oh.corhealth | R4 | CorHealth45AcuteCoronarySyndromeClassificationVS | Acute Coronary Syndrome Classification | active | ||||||
| hl7.eu.fhir.pcsp | R4 | vs-Gvhd-acute-grade-eu-pcsp | Acute Gvhd Grade | draft | 2025-07 | eu | hl7 | internal tho | ||
| hl7.eu.fhir.pcsp | R4 | vs-Gvhd-chronic-grade-eu-pcsp | Chronic Gvhd condition | draft | 2025-07 | eu | hl7 | internal tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) | active | 2009-01 | us | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) | active | 2009-01 | us | loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) | active | 2009-01 | us | sct | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | 2024-06 | us | hl7 | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.20 | Telecom Use (US Realm Header) | active | 2024-06 | us | hl7 | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.19579 | Family Member Value | active | 2024-06 | us | hl7 | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.38 | Smoking Status | active | 2024-06 | us | hl7 | sct | ||
| robin.gittest | R4 | be-vs-addiction-category | Addiction Category | draft | 2021-01 | |||||
| robin.gittest | R4 | be-vs-addiction-code | Addiction Code | draft | 2021-01 | |||||
| hl7.fhir.uv.tools | R5 | additional-binding-purpose | Additional Binding Purpose ValueSet | informative | 4 | fhir | 2025-07 | uv | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3162 | Risk Factors (TB) | active | 2008-01 | us | sct tho oid | |||
| ch.fhir.ig.ch-term | R4 | condition-category | Condition Category Codes | active | 2025-05 | ch | hl7 | |||
| gov.healthit.ecqi.ecqms.subset | R4 | extended-usage-context-type | Extended Usage Context Type | active | 2025-06 | tho | ||||
| hl7.fhir.uv.cardx-cied | R5 | cied-connectivity-state-modifier-vs | CIED Connectivity Status Modifier Value Set | trial-use | 2 | cic | 2025-07 | uv | hl7 | fhir |
| tewhatuora.hip-core | R4 | nhi-name-use-extra-1.0 | NHI Name Use Extra | active | 2022-04 | national | ||||
| healthdata.be.r4.cbb | R4 | AdditionalWishes | AdditionalWishes | draft | oid | |||||
| ForgePatientChart.0830 | R4 | telus-address-state | TELUS ValueSet - Address State | draft | 2020-11 | hl7 | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.801 | Address Type (HL7) | active | 2018-01 | us | tho | |||
| hl7.fhir.us.davinci-crd | R4 | locationAddressType | CRD Location Address Types Value Set | trial-use | 4 | fm | 2025-07 | us | hl7 | fhir |
| ee.fhir.terminology | R5 | ads-adr-id | ADS AdrId | active | 2025-06 | ee | hl7 | internal | ||
| ee.fhir.terminology | R5 | ads-oid | ADS Oid | active | 2025-06 | ee | hl7 | internal | ||
| hl7.fhir.us.davinci-hrex | R4 | hrex-coverage-relationship | HRex Coverage Relationship ValueSet | draft | 0 | cic | 2025-04 | us | hl7 | fhir tho |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | 2024-03 | us | hl7 | vsac | ||
| nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.285--20200616133418 | Ademhaling | active | nl | fhir sct | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20200901000000 | AdemhalingScoreCodelijst | active | nl | hl7 | loinc | |||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20171231000000 | AdemhalingScoreCodelijst | active | nl | loinc | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.3--20200901000000 | AdemhalingsreactieCodelijst | active | nl | hl7 | oid | |||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.3--20171231000000 | AdemhalingsreactieCodelijst | active | nl | oid | ||||
| hl7.fhir.uv.emedicinal-product-info | R5 | administrableDoseForm | Administrable Pharmaceutical Dose Form | active | 2025-07 | uv | hl7 | fhir | ||
| ans.fr.terminologies | R4 | jdv-hl7-v3-AdministrableDrugForm-cisis | AdministrableDrugForm | active | 2025-06 | fr | national | tho | ||
| dk.kip.rkkp.fhir.ig.core | R4 | AdministrationTypeDCCG | Administrationstype Jern (DCCG) | active | 2022-11 | internal | ||||
| hl7.terminology | R5 | v3-AdministrationDetectedIssueCode | AdministrationDetectedIssueCode | active | 2014-03 | uv | hl7 | tho | ||
| healthdata.be.r4.cbb | R4 | AdministrationAgreementAdditionalInformation | AdministrationAgreementAdditionalInformation | draft | oid |
FHIR